Valneva SE (VALN) EBT Margin (2021 - 2026)

Valneva SE's (VALN) quarterly EBT Margin came in at 102.4% in Q1 2026, down 8644.0% year-on-year from 1.2% in Q1 2025, and up 22.82% quarter-over-quarter from 132.67% in Q4 2025.

Valneva SE (VALN) EBT Margin (2021 - 2026) Analysis & Trends

Valneva SE has disclosed EBT Margin across 6 years of filings, most recently posting 102.4% for Q1 2026.

  • EBT Margin for Q1 2026 came in at 102.4%, down 8644.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 99.07% (down 5552.0% YoY), and the FY2025 annual result was 72.27%, down 6524.0% from the prior year.
  • EBT Margin came in at 102.4% for Q1 2026 at Valneva SE, up from 132.67% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 183.27% in Q1 2024 to a low of 836.68% in Q2 2022.
  • The 5-year median for EBT Margin is 63.68% (2024), against an average of 94.48%.
  • Peak annual rise in EBT Margin reached 133275 bps in 2022, while the deepest fall reached 111383 bps in 2022.
  • Valneva SE's EBT Margin stood at 118.64% in 2022, then jumped by 50 bps to 59.38% in 2023, then declined by 7 bps to 63.68% in 2024, then slumped by 108 bps to 132.67% in 2025, then grew by 23 bps to 102.4% in 2026.
  • The last three EBT Margin figures came in at 102.4% (Q1 2026), 132.67% (Q4 2025), and 153.18% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 6.40%
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 41.95%
9 Abivax 94.26 Bn 94.26 Bn - -
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -102.40%

Historic Data

Download Data
DateValue
Mar 31, 2026 -102.40%
Dec 31, 2025 -132.67%
Sep 30, 2025 -153.18%
Jun 30, 2025 -27.84%
Mar 31, 2025 -15.96%
Dec 31, 2024 -63.68%
Sep 30, 2024 -29.30%
Jun 30, 2024 -69.47%
Mar 31, 2024 183.27%
Dec 31, 2023 -59.38%
Sep 30, 2023 -86.52%
Jun 30, 2023 -54.78%
Mar 31, 2023 -56.84%
Dec 31, 2022 -118.64%
Sep 30, 2022 176.00%
Jun 30, 2022 -836.68%
Mar 31, 2022 -158.02%
Dec 31, 2021 995.19%
Sep 30, 2021 -1,156.75%
Jun 30, 2021 -368.72%